138 related articles for article (PubMed ID: 28620648)
1. Effect of Fc-γ Receptor Polymorphism on Rituximab-Mediated B Cell Depletion in ABO-Incompatible Adult Living Donor Liver Transplantation.
Sakai H; Tanaka Y; Tazawa H; Shimizu S; Verma S; Ohira M; Tahara H; Ide K; Ishiyama K; Kobayashi T; Onoe T; Ohdan H
Transplant Direct; 2017 Jun; 3(6):e164. PubMed ID: 28620648
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with rituximab-mediated B cell depletion in ABO-incompatible adult living donor liver transplantation.
Hong SK; Lee KW; Kim JY; Lee J; Kim J; Choi HH; Hong SY; Lee JM; Choi Y; Yi NJ; Suh KS
Korean J Transplant; 2023 Sep; 37(3):170-178. PubMed ID: 37694598
[TBL] [Abstract][Full Text] [Related]
3. Fc-Gamma Receptor Polymorphisms Predispose Patients to Infectious Complications After Liver Transplantation.
Shimizu S; Tanaka Y; Tazawa H; Verma S; Onoe T; Ishiyama K; Ohira M; Ide K; Ohdan H
Am J Transplant; 2016 Feb; 16(2):625-33. PubMed ID: 26517570
[TBL] [Abstract][Full Text] [Related]
4. FCGR3A and FCGR2A Genotypes Differentially Impact Allograft Rejection and Patients' Survival After Lung Transplant.
Paul P; Pedini P; Lyonnet L; Di Cristofaro J; Loundou A; Pelardy M; Basire A; Dignat-George F; Chiaroni J; Thomas P; Reynaud-Gaubert M; Picard C
Front Immunol; 2019; 10():1208. PubMed ID: 31249568
[TBL] [Abstract][Full Text] [Related]
5. Effect of FCGR polymorphism on the occurrence of late-onset neutropenia and flare-free survival in rheumatic patients treated with rituximab.
Ajeganova S; Tesfa D; Hägglund H; Fadeel B; Vedin I; Zignego AL; Palmblad J
Arthritis Res Ther; 2017 Mar; 19(1):44. PubMed ID: 28270182
[TBL] [Abstract][Full Text] [Related]
6. Impact of Human FcγR Gene Polymorphisms on IgG-Triggered Cytokine Release: Critical Importance of Cell Assay Format.
Hussain K; Hargreaves CE; Rowley TF; Sopp JM; Latham KV; Bhatta P; Sherington J; Cutler RM; Humphreys DP; Glennie MJ; Strefford JC; Cragg MS
Front Immunol; 2019; 10():390. PubMed ID: 30899264
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive genetic and functional analyses of Fc gamma receptors influence on response to rituximab therapy for autoimmunity.
Robinson JI; Md Yusof MY; Davies V; Wild D; Morgan M; Taylor JC; El-Sherbiny Y; Morris DL; Liu L; Rawstron AC; Buch MH; Plant D; Cordell HJ; Isaacs JD; Bruce IN; Emery P; Barton A; Vyse TJ; Barrett JH; Vital EM; Morgan AW; ;
EBioMedicine; 2022 Dec; 86():104343. PubMed ID: 36371989
[TBL] [Abstract][Full Text] [Related]
8. Fc-gamma receptor 3A polymorphism predicts the incidence of urinary tract infection in kidney-transplant recipients.
Das LK; Ide K; Tanaka A; Morimoto H; Shimizu S; Tanimine N; Tanaka Y; Ohdan H
Hum Immunol; 2017 Apr; 78(4):357-362. PubMed ID: 28315348
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Fcγ receptor IIIa and IIa polymorphisms: lack of correlation with outcome in trastuzumab-treated breast cancer patients.
Hurvitz SA; Betting DJ; Stern HM; Quinaux E; Stinson J; Seshagiri S; Zhao Y; Buyse M; Mackey J; Driga A; Damaraju S; Sliwkowski MX; Robert NJ; Valero V; Crown J; Falkson C; Brufsky A; Pienkowski T; Eiermann W; Martin M; Bee V; Marathe O; Slamon DJ; Timmerman JM
Clin Cancer Res; 2012 Jun; 18(12):3478-86. PubMed ID: 22504044
[TBL] [Abstract][Full Text] [Related]
10. A functional variant of Fcgamma receptor IIIA is associated with rheumatoid arthritis in individuals who are positive for anti-glucose-6-phosphate isomerase antibodies.
Matsumoto I; Zhang H; Muraki Y; Hayashi T; Yasukochi T; Kori Y; Goto D; Ito S; Tsutsumi A; Sumida T
Arthritis Res Ther; 2005; 7(6):R1183-8. PubMed ID: 16277670
[TBL] [Abstract][Full Text] [Related]
11. Impact of Fc gamma-receptor polymorphisms on the response to rituximab treatment in children and adolescents with mature B cell lymphoma/leukemia.
Burkhardt B; Yavuz D; Zimmermann M; Schieferstein J; Kabickova E; Attarbaschi A; Lisfeld J; Reiter A; Makarova O; Worch J; Bonn BR; Damm-Welk C
Ann Hematol; 2016 Sep; 95(9):1503-12. PubMed ID: 27376362
[TBL] [Abstract][Full Text] [Related]
12. Comparison of acute kidney injury between ABO-compatible and ABO-incompatible living donor liver transplantation: A propensity matching analysis.
Jun IG; Lee B; Kim SO; Shin WJ; Bang JY; Song JG; Song GW; Lee SG; Hwang GS
Liver Transpl; 2016 Dec; 22(12):1656-1665. PubMed ID: 27595780
[TBL] [Abstract][Full Text] [Related]
13. Feasible usage of ABO incompatible grafts in living donor liver transplantation.
Ikegami T; Yoshizumi T; Soejima Y; Uchiyama H; Shirabe K; Maehara Y
Hepatobiliary Surg Nutr; 2016 Apr; 5(2):91-7. PubMed ID: 27115002
[TBL] [Abstract][Full Text] [Related]
14. Long-term Outcomes of ABO-incompatible Pediatric Living Donor Liver Transplantation.
Honda M; Sugawara Y; Kadohisa M; Shimata K; Sakisaka M; Yoshii D; Uto K; Hayashida S; Ohya Y; Yamamoto H; Yamamoto H; Inomata Y; Hibi T
Transplantation; 2018 Oct; 102(10):1702-1709. PubMed ID: 29620615
[TBL] [Abstract][Full Text] [Related]
15. Single-nucleotide polymorphisms and copy number variations of the
Moriya H; Saito K; Helsby N; Hayashi N; Sugino S; Yamakage M; Sawaguchi T; Takasaki M; Takahashi M; Kurosawa N
Biomed Rep; 2014 Mar; 2(2):265-269. PubMed ID: 24649108
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene.
Cartron G; Dacheux L; Salles G; Solal-Celigny P; Bardos P; Colombat P; Watier H
Blood; 2002 Feb; 99(3):754-8. PubMed ID: 11806974
[TBL] [Abstract][Full Text] [Related]
17. Association between functional FCGR3A F158V and FCGR2A R131H polymorphisms and responsiveness to rituximab in patients with autoimmune diseases: a meta-analysis.
Lee YH; Song GG
Pharmacogenomics J; 2023 Nov; 23(6):210-216. PubMed ID: 37149714
[TBL] [Abstract][Full Text] [Related]
18. ABCB1, FCGR2A, and FCGR3A polymorphisms in patients with HER2-positive metastatic breast cancer who were treated with first-line taxane plus trastuzumab chemotherapy.
Kim JW; Kim JH; Im SA; Kim YJ; Han HS; Kim JS; Han SW; Jeon YK; Oh DY; Han W; Kim TY; Park IA; Noh DY; Bang YJ
Oncology; 2012; 83(4):218-27. PubMed ID: 22906996
[TBL] [Abstract][Full Text] [Related]
19. The changes in treatment strategies in ABOi living donor liver transplantation for acute liver failure.
Yasuda M; Ikegami T; Imai D; Wang H; Bekki Y; Itoh S; Yoshizumi T; Soejima Y; Shirabe K; Maehara Y
J Med Invest; 2015; 62(3-4):184-7. PubMed ID: 26399345
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Liver Graft Regeneration Between ABO-Compatible and ABO-Incompatible Living Donor Liver Transplantation: A Propensity Score Matching Analysis.
Chae MS; Lee N; Choi HJ; Chung HS; Park CS; Lee J; Choi JH; Hong SH
Ann Transplant; 2018 Jul; 23():507-519. PubMed ID: 30050031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
